Effect of Red Ginseng on Blood Pressure in Patients with Essential Hypertension and White Coat Hypertension
- 1 January 1998
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 26 (2), 199-209
- https://doi.org/10.1142/s0192415x98000257
Abstract
The objective of this study is to evaluate the changes of diurnal blood pressure pattern after 8 weeks of red ginseng medication (4.5 g/day) by 24 hour ambulatory blood pressure monitoring. In 26 subjects with essential hypertension, 24 hour mean systolic blood pressure decreased significantly (p = 0.03) while diastolic blood pressure only showed a tendency of decline (p = 0.17). The decrease in pressures were observed at daytime (8 A.M.-6 P.M.) and dawn (5 A.M.-7 A.M.). In 8 subjects with white coat hypertension, no significant blood pressure change was observed. We suggest that red ginseng might be useful as a relatively safe medication adjuvant to current antihypertensive medications.Keywords
This publication has 9 references indexed in Scilit:
- Diagnosis of mild hypertension by ambulatory blood pressure monitoring.Circulation, 1994
- Population-Derived Comparisons of Ambulatory and Office Blood PressuresArchives of Internal Medicine, 1992
- The decline of atrial natriuretic peptide (ANP) gene expression in older rats and the effects of ginsenoside on ANP gene expressionComparative Biochemistry and Physiology Part B: Comparative Biochemistry, 1992
- Anti-Stress Effect of Ginseng on the Inhibition of the Development of Morphine Tolerance in Stressed Mice.The Japanese Journal of Pharmacology, 1992
- Pharmacological studies of nutritive and tonic crude drugs on fatigue in mice.Folia Pharmacologica Japonica, 1992
- Blood pressure reduction and the prevention of strokeJournal of Hypertension, 1991
- Validation of portable noninvasive blood pressure monitoring devices: Comparisons with intra-arterial and sphygmomanometer measurementsAmerican Heart Journal, 1988
- Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)Journal of Hypertension, 1985
- MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.BMJ, 1985